三角防務(300775.SZ):300MN等温模鍛液壓機成功實現熱載試車
格隆匯 4 月 1日丨三角防務(300775.SZ)公佈,公司首次公開發行股票募投項目之“發動機盤環件先進製造生產線建設項目”中的300MN等温模鍛液壓機於2021年3月31日實現等温鍛造和普通鍛造雙模式熱載試車。設備具備等温鍛、熱模鍛及常規鍛造不同工作模式,可滿足高温合金、鈦合金及粉末合金等難變形合金鍛件的等温鍛、熱模鍛、模鍛成型。
由於生產設備從試車成功到全面達產併產生經濟效益還需一定的時間,對財務盈利的影響具有不確定性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.